|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mottet N, Bellmunt J, Bolla M, et al: EAU
guidelines on prostate cancer. Part II: Treatment of advanced,
relapsing, and castration-resistant prostate cancer. Actas Urol
Esp. 35:565–579. 2011.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chuu CP, Kokontis JM, Hiipakka RA, et al:
Androgens as therapy for androgen receptor-positive
castration-resistant prostate cancer. J Biomed Sci. 18:632011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harzstark AL and Small EJ:
Castrate-resistant prostate cancer: therapeutic strategies. Expert
Opin Pharmacother. 11:937–945. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Theodoratou E, Kyle J, Cetnarskyj R, et
al: Dietary flavonoids and the risk of colorectal cancer. Cancer
Epidemiol Biomarkers Prev. 16:684–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi JA, Kim JY, Lee JY, et al: Induction
of cell cycle arrest and apoptosis in human breast cancer cells by
quercetin. Int J Oncol. 19:837–844. 2001.PubMed/NCBI
|
|
7
|
Kim MJ, Kim YJ, Park HJ, Chung JH, Leem KH
and Kim HK: Apoptotic effect of red wine polyphenols on human colon
cancer SNU-C4 cells. Food Chem Toxicol. 44:898–902. 2006.
View Article : Google Scholar
|
|
8
|
Tang SN, Singh C, Nall D, Meeker D,
Shankar S and Srivastava RK: The dietary bioflavonoid quercetin
synergizes with epigallocathechin gallate (EGCG) to inhibit
prostate cancer stem cell characteristics, invasion, migration and
epithelial-mesenchymal transition. J Mol Signal. 5:142010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Srivastava RK, Tang SN, Zhu W, Meeker D
and Shankar S: Sulforaphane synergizes with quercetin to inhibit
self-renewal capacity of pancreatic cancer stem cells. Front Biosci
(Elite Ed). 3:515–528. 2011. View
Article : Google Scholar
|
|
10
|
Zou Y, Lu Y and Wei D: Antioxidant
activity of a flavonoid-rich extract of Hypericum perforatum L. in
vitro. J Agric Food Chem. 52:5032–5039. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao LL, Feng L, Yao ST, et al: Molecular
mechanisms of celery seed extract induced apoptosis via s phase
cell cycle arrest in the BGC-823 human stomach cancer cell line.
Asian Pac J Cancer Prev. 12:2601–2606. 2011.
|
|
12
|
Mertens-Talcott SU, Talcott ST and
Percival SS: Low concentrations of quercetin and ellagic acid
synergistically influence proliferation, cytotoxicity and apoptosis
in MOLT-4 human leukemia cells. J Nutr. 133:2669–2674.
2003.PubMed/NCBI
|
|
13
|
George J, Singh M, Srivastava AK, et al:
Resveratrol and black tea polyphenol combination synergistically
suppress mouse skin tumors growth by inhibition of activated MAPKs
and p53. PLoS One. 6:e233952011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar :
|
|
15
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar
|
|
16
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Liu W, Chao T, et al: MicroRNA-21
down-regulates the expression of tumor suppressor PDCD4 in human
glioblastoma cell T98G. Cancer Lett. 272:197–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frémont L: Biological effects of
resveratrol. Life Sci. 66:663–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brauns SC, Dealtry G, Milne P, Naudé R and
Van de Venter M: Caspase-3 activation and induction of PARP
cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells.
Anticancer Res. 25:4197–4202. 2005.PubMed/NCBI
|
|
20
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37(Pt 4): 918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carew JS and Huang P: Mitochondrial
defects in cancer. Mol Cancer. 9:92002. View Article : Google Scholar
|
|
22
|
Fresco P, Borges F, Diniz C and Marques
MP: New insights on the anticancer properties of dietary
polyphenols. Med Res Rev. 26:747–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schumacker PT: Reactive oxygen species in
cancer cells: live by the sword, die by the sword. Cancer Cell.
10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ling YH, Liebes L, Zou Y and Perez-Soler
R: Reactive oxygen species generation and mitochondrial dysfunction
in the apoptotic response to Bortezomib, a novel proteasome
inhibitor, in human H460 non-small cell lung cancer cells. J Biol
Chem. 278:33714–33723. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Biasutto L, Szabo’ I and Zoratti M:
Mitochondrial effects of plant-made compounds. Antioxid Redox
Signal. 15:3039–3059. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu SC, Lu JH, Kuo CL, et al: Crude
extracts of Solanum lyratum induced cytotoxicity and apoptosis in a
human colon adenocarcinoma cell line (colo 205). Anticancer Res.
28(2A): 1045–1054. 2008.PubMed/NCBI
|
|
27
|
Schlachterman A, Valle F, Wall KM, et al:
Combined resveratrol, quercetin, and catechin treatment reduces
breast tumor growth in a nude mouse model. Transl Oncol. 1:19–27.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tan J, Wang B and Zhu L: Regulation of
survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin.
Chem Biodivers. 6:1101–1110. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shakibaei M, John T, Seifarth C and
Mobasheri A: Resveratrol inhibits IL-1 beta-induced stimulation of
caspase-3 and cleavage of PARP in human articular chondrocytes in
vitro. Ann NY Acad Sci. 1095:554–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang ZQ, Stingl L, Morrison C, et al: PARP
is important for genomic stability but dispensable in apoptosis.
Genes Dev. 11:2347–2358. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu CP, Lin YH, Chou CC, et al: Mechanisms
of grape seed procyanidin-induced apoptosis in colorectal carcinoma
cells. Anticancer Res. 29:283–289. 2009.PubMed/NCBI
|
|
32
|
Li T, Li D, Sha J, Sun P and Huang Y:
MicroRNA-21 directly targets MARCKS and promotes apoptosis
resistance and invasion in prostate cancer cells. Biochem Biophys
Res Commun. 383:280–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ribas J, Ni X, Haffner M, et al: miR-21:
an androgen receptor-regulated microRNA that promotes
hormone-dependent and hormone-independent prostate cancer growth.
Cancer Res. 69:7165–7169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pang Y, Young CY and Yuan H: MicroRNAs and
prostate cancer. Acta Biochim Biophys Sin (Shanghai). 42:363–369.
2010. View Article : Google Scholar
|
|
35
|
Arbuzova A, Schmitz AA and Vergères G:
Cross-talk unfolded: MARCKS proteins. Biochem J. 362(Pt 1): 1–12.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang HS, Jansen AP, Komar AA, et al: The
transformation suppressor Pdcd4 is a novel eukaryotic translation
initiation factor 4A binding protein that inhibits translation. Mol
Cell Biol. 23:26–37. 2003. View Article : Google Scholar :
|
|
37
|
Bitomsky N, Böhm M and Klempnauer KH:
Transformation suppressor protein Pdcd4 interferes with
JNK-mediated phosphorylation of c-Jun and recruitment of the
coactivator p300 by c-Jun. Oncogene. 23:7484–7493. 2004. View Article : Google Scholar : PubMed/NCBI
|
